Title: Increasing African Immigrant’s Breast Cancer Screening

Principal Investigator: Jamilia R Sly, PhD, Icahn School of Medicine at Mount Sinai, New York, New York

Description: Because many African immigrant women in New York City are likely to live below the poverty line and have low health literacy and are less likely to have health insurance and visit a doctor, researchers are seeking to improve the rate of breast cancer screening within this population via a clinical trial.

While the barriers to breast cancer screening for other minority groups, such as African Americans and Latina women, have been studied, less is known about the barriers for African immigrant women. Researchers are seeking to learn how to most effectively engage their participation in regular screening.


Continue Reading

The study team is collaborating with the African Services Committee and the African Advisory Council of the Bronx, two non-governmental community-based service organizations, to conduct their research. The randomized clinical trial will test the adapted intervention to increase breast cancer screening rates for African-born immigrants. In the short term, the researchers plan to identify barriers and facilitators to breast cancer screening among African-born immigrants and culturally adapt and pilot test the Witness Project breast cancer education program for African-born women. All participants will receive the same breast cancer education intervention as the purpose of the current study is to assess feasibility and acceptability of the intervention. The intervention will, however, be delivered in English or French in accordance with the language preference of the participant.

To read the full list of participant criteria please refer to the reference.

Status: This study is ongoing and recruiting patients as of February 5, 2020.

This study is sponsored by Icahn School of Medicine at Mount Sinai.

Reference

Clinicaltrials.gov. Increasing African Immigrant Women’s Participation in Breast Cancer Screening (AIBCS). NCT04450264. https://clinicaltrials.gov/ct2/show/NCT04450264. Accessed October 15, 2020.